“…It is now clear that aggressive control of hyperglycemia in patients with diabetes can prevent or delay the onset of complications such as retinopathy, nephropathy, and neuropathy (Kumar et al, 2007). We have found that oxazolidines and related oxazolidine are classes of heterocycles that are of considerable interest because of the diverse range of their biological properties, such as antihypertensive (Caroon et al, 1983), antidepressant (Pinder, 1985), antithyroid (Gardrat and Latxague, 1990), leishmanicidal (Sonika and Satyavan, 1990), antidiabetic (Heong et al, 2007), anti-HIV (Sharma et al, 2003), antiarrhythmic (Kostochka et al, 2003), antitumor (Vara Prasad et al, 2006), and anticonvulsant and antimicrobial (Kim et al, 2008). This background information led to the design of 3-benzyl-2-(4'-substituted phenyl)-4(5H)-(4''-nitrophenyl amino)-1, 3-oxazolidine derivatives (6a-e).…”